Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR7 | P34969 | 1/20 | 0.31 |
| ▸ | HTR6 | P50406 | 1/20 | 0.31 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3205862 | 1.00 | LMNA (0.32) | LMNAMAPTHTR1AHTR2AHTR7 | |
| SCHEMBL1551748 | 1.00 | LMNA (0.32) | LMNAMAPTHTR1AHTR2AHTR7 | |
| SCHEMBL1551232 | 0.86 | TAS1R3 (0.39) | LMNAMAPT | |
| SCHEMBL1552304 | 0.86 | TAS1R3 (0.39) | LMNAMAPT | |
| SCHEMBL1551773 | 0.86 | TAS1R3 (0.39) | LMNAMAPT | |
| SCHEMBL1552530 | 0.84 | HTR1A (0.34) | LMNAMAPTHTR1AHTR2AHTR7 | |
| SCHEMBL1552292 | 0.84 | HTR1A (0.34) | LMNAMAPTHTR1AHTR2AHTR7 | |
| SCHEMBL1552303 | 0.84 | HTR1A (0.34) | LMNAMAPTHTR1AHTR2AHTR7 | |
| SCHEMBL1551293 | 0.83 | PFKFB3 (0.39) | LMNAMAPT | |
| SCHEMBL5428899 | 0.83 | PFKFB3 (0.39) | LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2012588-B1 | AQUEOUS SUSPENSION CONCENTRATE | BAYER CROPSCIENCE AG (DE) | 2011-04-27 | — | — | EP | disclosed |
| EP-1854355-A1 | Aqueous suspension concentrates | Bayer CropScience AG (DE) | 2007-11-14 | — | — | EP | disclosed |
| US-20070219095-A1 | AQUEOUS SUSPENSION CONCENTRATES | BAYER CROPSCIENCE GMBH (DE) | 2007-09-20 | — | — | US | disclosed |
| US-20070123424-A1 | AQUEOUS SUSPENSION CONCENTRATES | BAYER CROPSCIENCE GMBH (DE) | 2007-05-31 | — | — | US | disclosed |
| EP-1790227-A1 | Aqueous suspension-concentrates of 2,4-diamino-s-triazine herbicides | Bayer CropScience AG (DE) | 2007-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123424-A1 | AQUEOUS SUSPENSION CONCENTRATES | ASH2L, SPATS2L, AS3MT | LMNA 4624/4885MAPT 685/4885HTR1A 1980/4885 |
| US-20070219095-A1 | AQUEOUS SUSPENSION CONCENTRATES | SLC43A1, AS3MT, SLC7A5 | LMNA 4673/4885MAPT 1576/4885HTR1A 1236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.